Danish Pharmacovigilance Update, 15 September 2011

26 September 2011

In this issue of Danish Pharmacovigilance Update:

  • Significant increase in off-label use of AeroBec® in children under the age of five
  • Inquiry about article in Danish Pharmacovigilance Update from January 2011 on fluoroquinolones and risk of QT prolongation
  • NSAIDs and possible risk of cardiac adverse reactions
  • Warning against the product Melanotan (the Barbie drug)
  • The Danish Medicines Agency wants to receive reports of suspected antibiotic resistance
  • The Danish Medicines Agency focuses attention on consumption and safety of biological medicines for children and adolescents
  • Danish Drug Interaction Database expanded with information about class effect, SAD products and product names for natural remedies and strong vitamins

Download the newsletter in the box to the right.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.